{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:13:57Z","timestamp":1794662037861,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","award":["1183338"],"award-info":[{"award-number":["1183338"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polygenic risk scores (PRSs) can predict the risk of colorectal cancer (CRC) and target screening more precisely than current guidelines using age and family history alone. Primary care, as a far-reaching point of healthcare and routine provider of cancer screening and risk information, may be an ideal location for their widespread implementation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This trial aims to determine whether the SCRIPT intervention results in more risk-appropriate CRC screening after 12 months in individuals attending general practice, compared with standard cancer risk reduction information. The SCRIPT intervention consists of a CRC PRS, tailored risk-specific screening recommendations and a risk report for participants and their GP, delivered in general practice. Patients aged between 45 and 70 inclusive, attending their GP, will be approached for participation. For those over 50, only those overdue for CRC screening will be eligible to participate. Two hundred and seventy-four participants will be randomised to the intervention or control arms, stratified by general practice, using a computer-generated allocation sequence. The primary outcome is risk-appropriate CRC screening after 12 months. For those in the intervention arm, risk-appropriate screening is defined using PRS-derived risk; for those in the control arm, it is defined using family history and national screening guidelines. Timing, type and results of the previous screening are considered in both arms. Objective health service data will capture screening behaviour. Secondary outcomes include cancer-specific worry, risk perception, predictors of CRC screening behaviour, screening intentions and health service use at 1, 6 and 12 months post-intervention delivery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This trial aims to determine whether a PRS-derived personalised CRC risk estimate delivered in primary care increases risk-appropriate CRC screening. A future population risk-stratified CRC screening programme could incorporate risk assessment within primary care while encouraging adherence to targeted screening recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian and New Zealand Clinical Trial Registry ACTRN12621000092897p. Registered on 1 February 2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06734-7","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T23:02:54Z","timestamp":1664233374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The SCRIPT trial: study protocol for a randomised controlled trial of a polygenic risk score to tailor colorectal cancer screening in primary care"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-6852","authenticated-orcid":false,"given":"Sibel","family":"Saya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patty","family":"Chondros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard De Abreu","family":"Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Marker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Winship","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finlay","family":"Macrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"6734_CR1","volume-title":"Cancer Data in Australia","author":"Australian Institute of Health and Welfare","year":"2021","unstructured":"Australian Institute of Health and Welfare. Cancer Data in Australia. Canberra: AIHW; 2021. Available from: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/data"},{"key":"6734_CR2","volume-title":"Health system expenditures on cancer and other neoplasms in Australia, 2000\u201301","author":"Australian Institute of Health and Welfare","year":"2005","unstructured":"Australian Institute of Health and Welfare. Health system expenditures on cancer and other neoplasms in Australia, 2000\u201301. 2005. Available from: https:\/\/www.aihw.gov.au\/reports\/health-welfare-expenditure\/health-system-expenditures-cancer-2000-01\/."},{"issue":"7","key":"6734_CR3","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/S2468-2667(17)30105-6","volume":"2","author":"JB Lew","year":"2017","unstructured":"Lew JB, St John DJB, Xu XM, Greuter MJE, Caruana M, Cenin DR, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. Lancet Public Health. 2017;2(7):e331\u2013e40.","journal-title":"Lancet Public Health"},{"issue":"1","key":"6734_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-5573-8-2","volume":"8","author":"JL Hopper","year":"2011","unstructured":"Hopper JL. Disease-specific prospective family study cohorts enriched for familial risk. Epidemiol Perspect Innov. 2011;8(1):2.","journal-title":"Epidemiol Perspect Innov"},{"issue":"10","key":"6734_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5694\/mja18.00142","volume":"209","author":"MA Jenkins","year":"2018","unstructured":"Jenkins MA, Ait Ouakrim D, Boussioutas A, Hopper JL, Ee HC, Emery JD, et al. Revised Australian national guidelines for colorectal cancer screening: family history. Med J Aust. 2018;209(10):455\u201360.","journal-title":"Med J Aust"},{"key":"6734_CR6","unstructured":"Cancer Council Australia Colorectal Cancer Guidelines Working Party. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney:\u00a0Cancer Council Australia; 2017. Available from: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer"},{"key":"6734_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5515","volume":"367","author":"LM Helsingen","year":"2019","unstructured":"Helsingen LM, Vandvik PO, Jodal HC, Agoritsas T, Lytvyn L, Anderson JC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367:l5515.","journal-title":"BMJ."},{"issue":"6","key":"6734_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1158\/1940-6207.CAPR-19-0521","volume":"13","author":"CL Saunders","year":"2020","unstructured":"Saunders CL, Kilian B, Thompson DJ, McGeoch LJ, Griffin SJ, Antoniou AC, et al. External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using UK biobank. Cancer Prev Res (Phila). 2020;13(6):509\u201320.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10","key":"6734_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002973","volume":"8","author":"CB Do","year":"2012","unstructured":"Do CB, Hinds DA, Francke U, Eriksson N. Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genet. 2012;8(10):e1002973.","journal-title":"PLoS Genet"},{"issue":"6","key":"6734_CR10","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138(6):2044\u201358.","journal-title":"Gastroenterology."},{"issue":"1","key":"6734_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41588-018-0286-6","volume":"51","author":"JR Huyghe","year":"2019","unstructured":"Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76\u201387.","journal-title":"Nat Genet"},{"issue":"4","key":"6734_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/fon.15.303","volume":"12","author":"MA Jenkins","year":"2016","unstructured":"Jenkins MA, Makalic E, Dowty JG, Schmidt DF, Dite GS, MacInnis RJ, et al. Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening. Future Oncol. 2016;12(4):503\u201313.","journal-title":"Future Oncol"},{"issue":"7","key":"6734_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ejhg.2017.60","volume":"25","author":"O Stanesby","year":"2017","unstructured":"Stanesby O, Jenkins M. Comparison of the efficiency of colorectal cancer screening programs based on age and genetic risk for reduction of colorectal cancer mortality. Eur J Hum Genet. 2017;25(7):832\u20138.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"6734_CR14","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1038\/s41467-020-17719-y","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Guo J, Ni G, Yang J, Visscher PM, Yengo L. Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations. Nat Commun. 2020;11(1):3865.","journal-title":"Nat Commun"},{"issue":"9869","key":"6734_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0140-6736(13)60619-4","volume":"381","author":"A Donzelli","year":"2013","unstructured":"Donzelli A. The benefits and harms of breast cancer screening. Lancet. 2013;381(9869):799\u2013800.","journal-title":"Lancet."},{"issue":"4","key":"6734_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng.2582","volume":"45","author":"H Burton","year":"2013","unstructured":"Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P. Public health implications from COGS and potential for risk stratification and screening. Nat Genet. 2013;45(4):349\u201351.","journal-title":"Nat Genet"},{"key":"6734_CR17","volume-title":"National Bowel Cancer Screening Program: monitoring report 2020","author":"Australian Institute of Health and Welfare","year":"2020","unstructured":"Australian Institute of Health and Welfare. National Bowel Cancer Screening Program: monitoring report 2020. Canberra: AIHW; 2020. Available from: https:\/\/www.aihw.gov.au\/reports\/cancer-screening\/national-bowel-cancer-screening-monitoring-2020"},{"issue":"9982","key":"6734_CR18","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/S0140-6736(15)60722-X","volume":"385","author":"VJ Dzau","year":"2015","unstructured":"Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, Goldman D. Aligning incentives to fulfil the promise of personalised medicine. Lancet. 2015;385(9982):2118\u20139.","journal-title":"Lancet."},{"issue":"6934","key":"6734_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature01626","volume":"422","author":"FS Collins","year":"2003","unstructured":"Collins FS, Green ED, Guttmacher AE, Guyer MS, Institute USNHGR. A vision for the future of genomics research. Nature. 2003;422(6934):835\u201347.","journal-title":"Nature."},{"key":"6734_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1102","volume":"352","author":"GJ Hollands","year":"2016","unstructured":"Hollands GJ, French DP, Griffin SJ, Prevost AT, Sutton S, King S, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016;352:i1102.","journal-title":"BMJ."},{"key":"6734_CR21","first-page":"CD007275","volume":"10","author":"TM Marteau","year":"2010","unstructured":"Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 2010;10:CD007275.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6734_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1037\/a0036568","volume":"70","author":"CM McBride","year":"2015","unstructured":"McBride CM, Birmingham WC, Kinney AY. Health psychology and translational genomic research: bringing innovation to cancer-related behavioral interventions. Am Psychol. 2015;70(2):91\u2013104.","journal-title":"Am Psychol"},{"issue":"2","key":"6734_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ygeno.2013.04.002","volume":"102","author":"KD Graves","year":"2013","unstructured":"Graves KD, Leventhal KG, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, et al. Behavioral and psychosocial responses to genomic testing for colorectal cancer risk. Genomics. 2013;102(2):123\u201330.","journal-title":"Genomics."},{"issue":"8","key":"6734_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.7326\/M14-0765","volume":"161","author":"DS Weinberg","year":"2014","unstructured":"Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, et al. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med. 2014;161(8):537\u201345.","journal-title":"Ann Intern Med"},{"issue":"2","key":"6734_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1258\/096914107781261927","volume":"14","author":"SR Cole","year":"2007","unstructured":"Cole SR, Smith A, Wilson C, Turnbull D, Esterman A, Young GP. An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14(2):73\u20135.","journal-title":"J Med Screen"},{"key":"6734_CR26","doi-asserted-by":"crossref","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: an introduction to the new Medical Research Council guidance. In: Killoran A, Kelly MP, editors. Evidence-based Public Health.\u00a0Oxford: Oxford University Press; 2009. p. 185\u2013202.","DOI":"10.1093\/acprof:oso\/9780199563623.003.012"},{"issue":"1","key":"6734_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s13063-018-2764-7","volume":"19","author":"JG Walker","year":"2018","unstructured":"Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, et al. The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial. Trials. 2018;19(1):397.","journal-title":"Trials."},{"issue":"1","key":"6734_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177(1):26\u201331.","journal-title":"Cell."},{"issue":"7355","key":"6734_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/475163a","volume":"475","author":"CD Bustamante","year":"2011","unstructured":"Bustamante CD, Burchard EG, De la Vega FM. Genomics for the world. Nature. 2011;475(7355):163\u20135.","journal-title":"Nature."},{"issue":"1","key":"6734_CR30","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10(1):3328.","journal-title":"Nat Commun"},{"issue":"6","key":"6734_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2217\/14622416.6.6.639","volume":"6","author":"W Ollier","year":"2005","unstructured":"Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics. 2005;6(6):639\u201346.","journal-title":"Pharmacogenomics."},{"key":"6734_CR32","first-page":"59","volume":"11","author":"N Mulder","year":"2018","unstructured":"Mulder N, Abimiku A, Adebamowo SN, de Vries J, Matimba A, Olowoyo P, et al. H3Africa: current perspectives. Pharmgenomics Pers Med. 2018;11:59\u201366.","journal-title":"Pharmgenomics Pers Med"},{"issue":"7","key":"6734_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrc1389","volume":"4","author":"LN Kolonel","year":"2004","unstructured":"Kolonel LN, Altshuler D, Henderson BE. The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer. 2004;4(7):519\u201327.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"6734_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1055-9965.EPI-19-0929","volume":"29","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Hua X, Win AK, MacInnis RJ, Gallinger S, Marchand LL, et al. A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors. Cancer Epidemiol Biomarkers Prev. 2020;29(3):549\u201357.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"6734_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1186\/s13063-021-05567-0","volume":"22","author":"S Milton","year":"2021","unstructured":"Milton S, McIntosh J, Boyd L, Karnchanachari N, Macrae F, Emery JD. Commentary: Pivoting during a pandemic: developing a new recruitment model for a randomised controlled trial in response to COVID-19. Trials. 2021;22(1):605.","journal-title":"Trials."},{"issue":"1","key":"6734_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12911-017-0407-7","volume":"17","author":"JG Walker","year":"2017","unstructured":"Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG, et al. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care. BMC Med Inform Decis Mak. 2017;17(1):13.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"6734_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.31128\/AFP-04-17-4195","volume":"47","author":"GY Kim","year":"2018","unstructured":"Kim GY, Walker JG, Bickerstaffe A, Hewabandu N, Pirotta M, Flander L, et al. The CRISP-Q study: communicating the risks and benefits of colorectal cancer screening. Aust J Gen Pract. 2018;47(3):139\u201345.","journal-title":"Aust J Gen Pract"},{"issue":"6","key":"6734_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.31128\/AJGP-11-17-4386","volume":"47","author":"JD Emery","year":"2018","unstructured":"Emery JD, Pirotta M, Macrae F, Walker JG, Qama A, Boussioutas A, et al. \u2018Why don\u2019t I need a colonoscopy?\u2019: a novel approach to communicating risks and benefits of colorectal cancer screening. Aust J Gen Pract. 2018;47(6):343.","journal-title":"Aust J Gen Pract"},{"issue":"3-4","key":"6734_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000508963","volume":"23","author":"S Saya","year":"2020","unstructured":"Saya S, McIntosh JG, Winship IM, Clendenning M, Milton S, Oberoi J, et al. A genomic test for colorectal cancer risk: is this acceptable and feasible in primary care? Public Health Genomics. 2020;23(3-4):110\u201321.","journal-title":"Public Health Genomics"},{"issue":"1","key":"6734_CR40","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1038\/s41467-020-17680-w","volume":"11","author":"WK Ho","year":"2020","unstructured":"Ho WK, Tan MM, Mavaddat N, Tai MC, Mariapun S, Li J, et al. European polygenic risk score for prediction of breast cancer shows similar performance in Asian women. Nat Commun. 2020;11(1):3833.","journal-title":"Nat Commun"},{"key":"6734_CR41","unstructured":"Zoom Video Communications. Zoom Meetings. San Jose; 2011."},{"key":"6734_CR42","volume-title":"Doxy.me","author":"Doxy.me Inc","year":"2021","unstructured":"Doxy.me Inc. Doxy.me. 2021."},{"key":"6734_CR43","volume-title":"How to do the test - National Bowel Cancer Screening Program","author":"National Bowel Cancer Screening Program","year":"2021","unstructured":"National Bowel Cancer Screening Program. How to do the test - National Bowel Cancer Screening Program 2021. Available from: https:\/\/www.health.gov.au\/initiatives-and-programs\/national-bowel-cancer-screening-program\/getting-a-bowel-screening-test\/how-to-do-the-bowel-screening-test#doing-the-test."},{"issue":"1","key":"6734_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12687-017-0310-z","volume":"9","author":"KFJ Stewart","year":"2018","unstructured":"Stewart KFJ, Wesselius A, Schreurs MAC, Schols A, Zeegers MP. Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis. J Community Genet. 2018;9(1):1\u201318.","journal-title":"J Community Genet"},{"issue":"1","key":"6734_CR45","doi-asserted-by":"publisher","first-page":"pkz086","DOI":"10.1093\/jncics\/pkz086","volume":"4","author":"SK Naber","year":"2020","unstructured":"Naber SK, Kundu S, Kuntz KM, Dotson WD, Williams MS, Zauber AG, et al. Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk: current status and future potential. JNCI Cancer Spectr. 2020;4(1):pkz086.","journal-title":"JNCI Cancer Spectr"},{"issue":"10","key":"6734_CR46","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-05-0482","volume":"15","author":"A Gurmankin Levy","year":"2006","unstructured":"Gurmankin Levy A, Shea J, Williams SV, Quistberg A, Armstrong K. Measuring perceptions of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1893\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"6734_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7326\/0003-4819-114-8-657","volume":"114","author":"C Lerman","year":"1991","unstructured":"Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med. 1991;114(8):657\u201361.","journal-title":"Ann Intern Med"},{"issue":"10","key":"6734_CR48","first-page":"825","volume":"6","author":"SW Vernon","year":"1997","unstructured":"Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 1997;6(10):825\u201332.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6734_CR49","volume-title":"Predicting health behaviour","author":"M Connor","year":"1996","unstructured":"Connor M, Sparks P. Theory of planned behaviour and health behaviour. In: Conner M, Norman P, editors. Predicting health behaviour. 2nd ed; 1996.","edition":"2"},{"issue":"5","key":"6734_CR50","doi-asserted-by":"publisher","first-page":"pkaa062","DOI":"10.1093\/jncics\/pkaa062","volume":"4","author":"S Saya","year":"2020","unstructured":"Saya S, Emery JD, Dowty JG, McIntosh JG, Winship IM, Jenkins MA. The impact of a comprehensive risk prediction model for colorectal cancer on a population screening program. JNCI Cancer Spectr. 2020;4(5):pkaa062.","journal-title":"JNCI Cancer Spectr"},{"issue":"3","key":"6734_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046857","volume":"11","author":"A Scott","year":"2021","unstructured":"Scott A, Bai TS, Zhang YT. Association between telehealth use and general practitioner characteristics during COVID-19: findings from a nationally representative survey of Australian doctors. BMJ Open. 2021;11(3):e046857.","journal-title":"BMJ Open"},{"issue":"2","key":"6734_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"6734_CR53","unstructured":"Cancer Council Australia Surveillance Colonoscopy Guidelines Working Party. Colorectal cancer\/Colonoscopy surveillance\/Malignant polyps. In: Clinical practice guidelines for surveillance colonoscopy. Sydney:\u00a0Cancer Council Australia; 2017. Available from: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer\/Colonoscopy_surveillance\/."},{"key":"6734_CR54","volume-title":"Stata Statistical Software","author":"StataCorp.","year":"2021","unstructured":"StataCorp. Stata Statistical Software. College Station: StataCorp LLC; 2021."},{"issue":"4","key":"6734_CR55","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1503\/cmaj.051625","volume":"175","author":"CE Hewitt","year":"2006","unstructured":"Hewitt CE, Torgerson DJ, Miles JN. Is there another way to take account of noncompliance in randomized controlled trials? CMAJ. 2006;175(4):347.","journal-title":"CMAJ."},{"issue":"7282","key":"6734_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bmj.322.7282.355","volume":"322","author":"DJ Torgerson","year":"2001","unstructured":"Torgerson DJ. Contamination in trials: is cluster randomisation the answer? BMJ. 2001;322(7282):355\u20137.","journal-title":"BMJ."},{"issue":"4","key":"6734_CR57","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/ije\/26.4.765","volume":"26","author":"DJ Slymen","year":"1997","unstructured":"Slymen DJ, Hovell MF. Cluster versus individual randomization in adolescent tobacco and alcohol studies: illustrations for design decisions. Int J Epidemiol. 1997;26(4):765\u201371.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"6734_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584\u201391.","journal-title":"Nat Genet"},{"issue":"10","key":"6734_CR59","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/1055-9965.EPI-19-0059","volume":"28","author":"L McGeoch","year":"2019","unstructured":"McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, et al. Risk prediction models for colorectal cancer incorporating common genetic variants: a systematic review. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1580\u201393.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"6734_CR60","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.pec.2021.08.008","volume":"105","author":"S Saya","year":"2022","unstructured":"Saya S, McIntosh JG, Winship IM, Milton S, Clendenning M, Kyriakides M, et al. Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practice. Patient Educ Couns. 2022;105(4):987\u201395.","journal-title":"Patient Educ Couns"},{"key":"6734_CR61","first-page":"45","volume-title":"Health behavior and health education: theory, research, and practice","author":"VL Champion","year":"2008","unstructured":"Champion VL, Skinner CS. The Health Belief Model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research, and practice. 4nd ed; 2008. p. 45\u201365.","edition":"4"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06734-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06734-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06734-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:03:56Z","timestamp":1664237036000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06734-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6734"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06734-7","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have obtained ethics approval through the University of Melbourne\u2019s Medicine and Dentistry Human Ethics Sub-Committee (ID2057592\/14467). The Australian Institute for Health and Welfare have granted approval for the collection of NBCSP data with individual, specific consent (IDEO2021\/2\/1248). Services Australia have granted approval for the collection of MBS data with individual, specific consent (RMS1454). Written informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"Not applicable \u2014 no identifying information will be presented of published in reports of the trial results. The study consent form is attached as Additional file .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"Genetype Pty. Ltd. has provided research support to JMc, DB, MJ and JE. RA is an employee of Genetype Pty. Ltd. The University of Melbourne has filed patents for the testing of the SNPs included in this analysis and has a licencing agreement with Genetype Pty. Ltd. for the use of these patents. Genetype Pty. Ltd. does not have input or ultimate authority in the study design; collection, management, analysis and interpretation of data; the writing of the report; and the decision to submit the report for publication. The authors declare no other competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"810"}}